Development of a Wilms' tumor antigen-specific T-cell receptor for clinical trials: engineered patient's T cells can eliminate autologous leukemia blasts in NOD/SCID mice.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples